Pfizer (PFE) Tops Q1 EPS by 2c, Offers FY Guidance

Pfizer (NYSE: PFE) reported Q1 EPS of $0.69, $0.02 better than the analyst estimate of $0.67. Revenue for the quarter came in at $12.8 billion versus the consensus estimate of $13.09 billion.

GUIDANCE:

Pfizer sees FY2017 EPS of $2.50-$2.60, versus the consensus of $2.55. Pfizer sees FY2017 revenue of $52-54 billion, versus the consensus of $53.15 billion.

For earnings history and earnings-related data on Pfizer (PFE) click here.

You May Also Be Interested In

• Pfizer's Litfulo meets Phase 3 endpoints for vitiligo treatment
• Onto Innovation gains on bullish RBC initiation citing advanced packaging growth
• McCormick & Co. (MKC) Tops Q3 EPS by 10c, Beats on Revenue; Offers EPS Guidance